Clinical Trials Browser

Unknown × Observational × Myelodysplastic Syndromes × Clear all

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms

NCT04460950 2024-04-10

Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

Unknown

237 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04517175 2020-08-18

Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?

Unknown

300 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00525746 2020-01-14

Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)

Unknown

191 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Neoplasms, Leukemia, Myeloid, Acute

NCT04060485 2019-08-19

Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results

Unknown

1,000 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT03659084 2018-09-06

GREFFE

Unknown

150 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02328950 2016-02-17

A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome

Unknown

50 enrolled

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00898118 2013-08-12

Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant

Unknown

125 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes

NCT01828619 2013-04-10

Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients

Unknown

60 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes

NCT00596999 2012-04-10

HPDSC

Unknown

6 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Sickle Cell, Metabolism, Inborn Errors, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, beta-Thalassemia, Hematologic Neoplasms, X-Linked Combined Immunodeficiency Diseases, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00315419 2010-04-21

Identifying Characteristics of Bone Marrow Failure Syndromes

Unknown

450 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Hemoglobinuria, Paroxysmal, Leukemia, Lymphoid, Myelodysplastic Syndromes, Purpura, Thrombocytopenic, Red-Cell Aplasia, Pure, Leukemia, Large Granular Lymphocytic

NCT00899327 2009-07-08

Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants

Unknown

200 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Clinical Trials

SANGUINE

Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?

Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)

Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results

GREFFE

A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome

Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant

Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients

HPDSC

Identifying Characteristics of Bone Marrow Failure Syndromes

Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants